Multiplex Assay Kit for Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay)

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 91-99 95
EDTA plasma(n=5) 88-96 93
heparin plasma(n=5) 78-103 83
sodium citrate plasma(n=5) 92-101 95

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-91% 89-97% 94-103% 97-105%
EDTA plasma(n=5) 81-91% 98-105% 78-91% 83-105%
heparin plasma(n=5) 91-103% 89-101% 82-93% 95-105%
sodium citrate plasma(n=5) 85-102% 88-97% 98-105% 78-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:ANG) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Science Alert Antiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats Scialert: Source
Respiratory Research Strain variation in response to lung ischemia: role of MMP-12 PubMed: 23061826
Blood biomarker for early blood brain barrier disruption in ischemic stroke patent:US20170199205A1
Biomedicine & Pharmacotherapy Development of a novel bivalent baculovirus vectors for complement resistance and sustained transgene expression and its application in anti-angiogenesis …
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB254Hu01 Recombinant Angiostatin (ANG) Positive Control; Immunogen; SDS-PAGE; WB.
PAB254Hu01 Polyclonal Antibody to Angiostatin (ANG) WB; IHC; ICC; IP.
MAB254Hu21 Monoclonal Antibody to Angiostatin (ANG) WB; IHC
MAB254Hu22 Monoclonal Antibody to Angiostatin (ANG) WB; IHC; ICC; IP.
MAB254Hu23 Monoclonal Antibody to Angiostatin (ANG) WB; IHC; ICC; IP.
MAB254Hu24 Monoclonal Antibody to Angiostatin (ANG) WB; IHC; ICC; IP.
MAB254Hu25 Monoclonal Antibody to Angiostatin (ANG) WB; IHC; ICC; IP.
SEB254Hu ELISA Kit for Angiostatin (ANG) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB254Hu Multiplex Assay Kit for Angiostatin (ANG) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.